[
The company has set an indicative price band of $70 to $78 per share and plans to sell 825 million shares, according to its latest filing with the US Securities and Exchange Commission (SEC). The offering could value Anthropic at more than $1 trillion, making it one of the world’s most valuable publicly traded technology companies.
However, Indian retail investors face a hurdle in securing shares at the IPO price, even though they are permitted to invest in overseas stocks.
Anthropic IPO subscription and listing details
Anthropic launched its IPO roadshow on November 10, seeking commitments from institutional investors ahead of its proposed Nasdaq listing.
The company is targeting November 19 for the start of trading under the ticker symbol ANT, according to Reuters. The date remains subject to the completion of the offering and regulatory formalities.Of the 825 million shares being offered, Anthropic will issue 801.35 million fresh shares, while existing shareholders will sell 23.65 million shares.
At the upper end of the price band, the offering could raise $64.4 billion.
The company has also secured a separate $26 billion private placement involving major technology investors, including Google, Nvidia and AMD. Combined proceeds from the IPO and related private investments could reach $90.4 billion.
Early reports suggest strong institutional interest in the offering, with MarketWatch reporting that demand has already made the issue several times oversubscribed. However, an official subscription multiple has not been publicly confirmed.
Can Indian investors apply for the Anthropic IPO?
Indian residents can legally invest in overseas securities under the Reserve Bank of India’s Liberalised Remittance Scheme (LRS). The scheme allows resident individuals to remit up to $250,000 per financial year for permitted overseas transactions, including investments in foreign stocks.
However, participation in a US IPO differs from applying for an Indian public issue.
US IPO allocations are generally controlled by investment banks and their distribution networks, with institutional investors receiving a substantial share of the available stock.
Indian investors typically do not have access to these allocations through ordinary overseas trading accounts. As a result, most retail investors in India will have to wait until Anthropic begins trading on Nasdaq before purchasing its shares.
How can Indians buy Anthropic shares after listing?
Once Anthropic lists in the US, eligible Indian residents can purchase its shares through overseas brokerage accounts that provide access to Nasdaq-listed stocks.
Platforms offering international equity investments may allow investors to fund their accounts through the LRS route, subject to documentation, foreign exchange regulations and brokerage requirements.
Investors generally need to complete know-your-customer formalities, submit the required tax documentation and remit money through an authorised banking channel.
Some GIFT City-based investment platforms also provide access to US equities, depending on their product offerings and regulatory arrangements. However, investors should confirm whether their chosen platform will support trading in Anthropic shares from the listing date.
Buying shares after listing also carries the risk of paying more than the IPO offer price if the stock opens at a premium.
Why is the Anthropic IPO attracting attention?
Founded in 2021 by former OpenAI executives, including Dario and Daniela Amodei, Anthropic has emerged as a major competitor in the global artificial intelligence industry. Its Claude AI models compete with products developed by OpenAI, Google and other technology companies.
The company’s revenue has grown rapidly as businesses increase spending on AI-powered software, coding tools and enterprise applications.
Anthropic reported more than $16 billion in revenue during the first half of 2026, according to its IPO disclosures.
However, the company remains unprofitable amid substantial spending on computing infrastructure and AI development.
The proposed listing comes during a period of heightened scrutiny of AI valuations, with investors questioning whether the industry’s extraordinary capital expenditure will generate sufficient returns.
Disclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser. Podishetti Akash and his ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclosures here.
https://img.etimg.com/thumb/msid-135765053,width-1200,height-900,imgsize-476988,overlay-etmarkets/articleshow.jpg
https://economictimes.indiatimes.com/markets/us-stocks/news/anthropic-ipo-can-indian-investors-apply-for-claude-makers-64-billion-share-sale-check-rules/articleshow/135764925.cms




